Total Multimedia -TMM, Inc. (“TMMI”orthe”Company”)(OTCPNK:TMMI). Website:http://www.tmmi.us TMMI TO BECOME A REPORTING COMPANY President and Chief Executive Officer, Susan Bala has announced TMMI will take steps to move the Company up to OTCQB as a reporting company. Ms. Bala will make a capital infusion to provide funds for professional audit services to have the Company externally […]
CHICAGO, IL / ACCESS Newswire / January 27, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the filing of a
NEW YORK, NY / ACCESS Newswire / January 27, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against FTAI Aviation Ltd. (NASDAQ:FTAI) and certain of its senior executives for potential violations of the federal securities laws. If you invested in FTAI Aviation, you are encouraged
NEW YORK, NY / ACCESS Newswire / January 27, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Crocs, Inc. (NASDAQ:CROX) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Crocs, you are encouraged to
https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities, including call options, of Five9, Inc. (NASDAQ: FIVN) between June 4, 2024 and August 8, 2024, both dates inclusive (the “Class Period”), of the important February 3, 2025 lead plaintiff deadline. So what: If you purchased Five9 securities during the Class
NEW YORK, NY / ACCESS Newswire / January 27, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Novo Nordisk A/S ("Novo" or the "Company") (NASDAQ:NVO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK, NY / ACCESS Newswire / January 27, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to
NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Kyverna Therapeutics, Inc. (NASDAQ:KYTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kyverna-therapeutics-inc-lawsuit-submission-form?prid=125410&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
"The Quantum Almanac: 2025-2026" Details Encryption Collapse Timelines, Practical PQC Roadmaps, and Qryptonic’s Proven Solutions NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / A startling 99% of Fortune 500 firms face crippling vulnerability when Q-Day arrives-the moment quantum computers can break classical encryption. The Quantum Almanac: 2025-2026, now exclusively available in
The following issues have been halted by CIRO: Company: Medexus Pharmaceuticals Inc. TSX Symbol: MDP All Issues: Yes Reason: Pending News Halt Time (ET): 03:33 PM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and